Rapamycin inhibits the in vitro release of soluble interleukin-2 receptor by activated peripheral blood mononuclear cells (PBMC) independently of the mode of activation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples